Driving Innovation Through Data-Driven Research

Our Research Initiatives

Real-World Data Analysis for Clinical Trials
Health Equity in Sickle Cell Disease Care
Novel Therapeutic Pathways & Drug Discovery
Global Patient Registry & Longitudinal Studies

Introducing Elliott AI™

The Future of Sickle Cell Innovation Starts Here

At PharmaSickle, we believe improving outcomes begins with better understanding. Elliott AI™ is our vision for a future where patient experiences, caregiver insights, education, community engagement, and data-driven innovation work together to support individuals and families affected by sickle cell disease.

By exploring new ways to connect information, resources, and real-world experiences, Elliott AI is designed to help uncover insights that can improve decision-making, strengthen support systems, advance research, and promote health equity. More than a technology initiative, Elliott AI represents a commitment to ensuring that the voices and experiences of patients and caregivers help shape the future of sickle cell care.